The Austen Riggs Center has been a leader in the field of psychiatry when it comes to integrating a psychodynamic approach into traditional medication management for individuals struggling with psychiatric illness.
In fact, our Director of Psychiatric Education David Mintz, MD, has authored a first-of-its-kind treatment manual entitled Psychodynamic Psychopharmacology: Caring for the Treatment-Resistant Patient
. In the book, Mintz explores some of the reasons that treatment-resistance is so common in psychiatric treatment, shows how a psychodynamic perspective can be joined with the evidence base that connects meaning and medication, illuminates common dynamics that contribute to pharmacologic treatment-resistance, and offers technical recommendations for addressing pharmacologic treatment resistance.
Our research, and the research of others, suggests that psychosocial aspects of medications are often more powerful than the active ingredients of those medications. Our psychodynamic perspective emphasizes that:
The evidence base that is incorporated into our psychodynamic psychopharmacology treatment model and treatment recommendations emphasizes, among other things, the role of: